Clinical studies recruiting near Bradenton

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Line
Phase 3 · Weinkle Dermatology · Ipsen · NCT07435428 Hydration & Female Life Stages
NA · GSSI Bradenton · PepsiCo Global R&D · NCT07653620 Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
NA · Manatee Memorial Hospital · Innova Vascular, Inc. · NCT06041594 Inspire UAS High Apnea Hypopnea Index (AHI)/High Body Mass Index (BMI) Post-Approval Study
Phase N/A · Florida Sleep Specialists · Inspire Medical Systems, Inc. · NCT07113288 Shoulder Innovations Clinical Data Registry
Phase N/A · Connolly Orthopedics · Shoulder Innovations · NCT06754150 A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Phase 2 · Bradenton Research Center, Inc. · Eli Lilly and Company · NCT05986292 A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (
Phase 3 · Nova Clinical Research - Bradenton- Site Number : 8400044 · Sanofi · NCT06290128 A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not
Phase 3 · Bradenton, FL Investigative Site FIN-10125 · Colorado Prevention Center · NCT06033950 A Study of Brenipatide in Participants With Opioid Use Disorder
Phase 2 · Bradenton Research Center, Inc. · Eli Lilly and Company · NCT07420283 The THOR IDE Study
NA · Manatee Memorial Hospital · Philips Clinical & Medical Affairs Global · NCT05916950 A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Phase 3 · Bradenton Research Center · Crystalys Therapeutics · NCT07089888 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 SELUTION 4 De Novo Small Vessel IDE Trial
NA · Manatee Memorial · M.A. Med Alliance S.A. · NCT05946629 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · Local Institution - 1015 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949 A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Al
Phase 3 · Key Clinical Research · Bristol-Myers Squibb · NCT07011745 Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult
Phase 3 · Florida Cancer Specialists · Pfizer · NCT07222800 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Florida Cancer Specialists - Bradenton Cancer Center · NRG Oncology · NCT04852887 LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · Synergy Healthcare · Boehringer Ingelheim · NCT06632457 Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigational site 9810 · Anthos Therapeutics, Inc. · NCT05712200 A Study of Dotinurad Versus Allopurinol in Participants With Gout
Phase 3 · Bradenton Research Center · Crystalys Therapeutics · NCT07089875 A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Phase 2 · Bradenton Research Center, Inc. · Eli Lilly and Company · NCT07285018 RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated
Phase 2 · Altimmune Clinical Study Site · Altimmune, Inc. · NCT07009860 A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants W
Phase 1/Phase 2 · Key Clinical Research LLC /ID# 277800 · AbbVie · NCT07599670 A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT
Phase 3 · Local Institution - 1015 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05511363 Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Phase 2/Phase 3 · Local Institution - 007-922-D · Mirati Therapeutics Inc. · NCT04613596 Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immu
Phase 3 · Comprehensive Hematology Oncology - Bradenton Clinic · OSE Immunotherapeutics · NCT06472245 A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associa
Phase 2 · Synergy Healthcare LLC · Regeneron Pharmaceuticals · NCT05519475 Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Phase 3 · Research Site · AstraZeneca · NCT06307652 Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Phase 4 · Florida Cancer Specialists · Pfizer · NCT06952660 A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Ca
Phase N/A · Nova Clinical Research, LLC · Takeda · NCT06538064

Look up another city

Look up another condition